2015
DOI: 10.1016/j.beproc.2015.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Intranasally administered oxytocin affects how dogs (Canis familiaris) react to the threatening approach of their owner and an unfamiliar experimenter

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
49
1
1

Year Published

2016
2016
2019
2019

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 51 publications
(57 citation statements)
references
References 38 publications
(9 reference statements)
6
49
1
1
Order By: Relevance
“…Dogs received a single intranasal dose of 12 IU (3 puffs) oxytocin (Syntocinon, Novartis) or placebo (isotonic sodium chloride 0.9% solution) in a double blind design that has already been proved to have both physiological (decreased heart rate and increased heart rate variability) and behavioral effects in dogs (e.g., Hernádi et al, 2015;Kis et al, 2015;Kovács et al, 2016). The oxytocin or placebo administration was followed by a 40-minutelong waiting period (following the protocol by Kis et al, 2014b) that is presumed to be necessary for the central neuropeptide levels to reach plateau (Born et al, 2002).…”
Section: Oxytocin or Placebo Treatmentmentioning
confidence: 99%
“…Dogs received a single intranasal dose of 12 IU (3 puffs) oxytocin (Syntocinon, Novartis) or placebo (isotonic sodium chloride 0.9% solution) in a double blind design that has already been proved to have both physiological (decreased heart rate and increased heart rate variability) and behavioral effects in dogs (e.g., Hernádi et al, 2015;Kis et al, 2015;Kovács et al, 2016). The oxytocin or placebo administration was followed by a 40-minutelong waiting period (following the protocol by Kis et al, 2014b) that is presumed to be necessary for the central neuropeptide levels to reach plateau (Born et al, 2002).…”
Section: Oxytocin or Placebo Treatmentmentioning
confidence: 99%
“…For example, polymorphisms in the oxytocin receptor ( OXTR ) gene were associated with dogs’ proximity seeking with the owner (Kis et al, 2014), rough temperament in cats (Arahori et al, 2015), and sociability in humans (Li et al, 2015). Furthermore, oxytocin has been associated with social fear (Kirsch et al, 2005), aggression toward unfamiliar individuals (Stallen et al, 2012) and social anxiety (Grillon et al, 2013) in humans, and friendliness toward a threatening human in dogs (Hernádi et al, 2015). In particular, Hernádi et al (2015) showed that dogs, after intranasal oxytocin administration, showed less friendliness toward the owner approaching them in a threatening way (in the so-called Threatening Approach test, originally developed and validated by Vas et al (2005, 2008) and looked more at their owners standing behind them than a control group of dogs who received a placebo.…”
Section: Introductionmentioning
confidence: 99%
“…In this way, the Topal group showed very recently in 2015 that dogs receiving intranasal oxytocin showed less friendly first reaction and individual differences in aggression to an unfamiliar experimenter, as compared to placebo, in a specific design behavioural task for dogs called Threatening Approach Test [50]. Also, in piglets, which are considered to be much more closer in brain anatomy, growth and development to the human brain, as compared for example to the classical rodent models [56], the group of Rault et al in Australia showed that neonatally oxytocin-treated piglets received and performed more aggressive behaviours, then the controls, possibly by reducing the HPA axis [51].…”
Section: Oxytocin and Aggressionmentioning
confidence: 99%
“…the vasopressin/oxytocin signalling systems are involved in a variety of functions such as reproduction, immunity and thermoregulation, but with focus on the social manifestations connected with affiliation and aggression [42]) and lately, there is increased interest in understanding the role of (especially intranasal) oxytocin on the main neuropsychiatric disorders such as autism [45], schizophrenia [46], anxiety [47], depression, Prader Willi syndrome [48] or even psychopathy [49] and the variety of behaviours exhibited by the relevant central areas, including aggression [50][51][52].…”
Section: Oxytocin and Aggressionmentioning
confidence: 99%
See 1 more Smart Citation